Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Parenteral Nutrition Market Growth Potential: How Will Market Size Shift Through 2030?
The parenteral nutrition market size has experienced strong growth in recent years. It is anticipated to increase from $7.09 billion in 2025 to $7.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. The expansion observed in the historical period can be linked to the increasing incidence of malnutrition, a rise in hospital admissions, insufficient awareness about parenteral nutrition, restricted homecare adoption, and the escalating demand for critical care nutrition.
The parenteral nutrition market is projected to experience substantial expansion in the coming years. It is anticipated to reach $9.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period can be linked to factors such as an increasing elderly population, the broadening of home healthcare provisions, advancements in nutrient compositions, governmental backing for nutrition initiatives, and the incorporation of digital monitoring into PN treatment. Key trends expected over the forecast period encompass sophisticated nutrient formulations, the proliferation of home parenteral nutrition, individualized nutrition therapy, less invasive administration tools, and improvements in regulatory adherence and safety.
Get A Free Sample Report With In-Depth Market Insights:
Parenteral Nutrition Market Growth Catalysts And Demand Drivers
The expansion of the parenteral nutrition market is anticipated to be spurred by the rising birth rate, which denotes the yearly count of live births per 1,000 individuals within the general population. An increase in both birth rates and fertility rates serves as a key indicator of a heightened risk of malnutrition among women of childbearing age and new mothers, thereby boosting the need for parenteral nutrition. As an illustration, in July 2025, data from the Office for National Statistics Census, a UK-based government agency, revealed that England and Wales registered 594,677 live births in 2024. This represented an increase of 3,605 births (0.6%) when compared to the 591,072 live births recorded in 2023, thus reaffirming the role of increasing birth rates in driving the parenteral nutrition market’s growth.
Parenteral Nutrition Market Segment Outlook: Which Categories Are Growing Fastest?
The parenteral nutrition market covered in this report is segmented –
1) By Composition: Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals, Other Compositions
2) By Consumer Type: Children and New-born, Adults
3) By End-User: Hospitals, Clinics, Homecare, Other End Users
Subsegments:
1) By Amino Acids: Essential Amino Acids, Non-Essential Amino Acids, Specialized Amino Acid Solutions
2) By Fats: Lipid Emulsions (Soybean Oil, Olive Oil), Fish Oil-Based Lipid Emulsions, Medium-Chain Triglycerides (MCTs)
3) By Carbohydrates: Dextrose Solutions, Maltodextrin, Fructose
4) By Trace Elements: Zinc, Copper, Selenium, Manganese
5) By Vitamins: Water-Soluble Vitamins (B-complex, Vitamin C), Fat-Soluble Vitamins (A, D, E, K)
6) By Minerals: Electrolytes (Sodium, Potassium, Calcium, Magnesium), Phosphorus
7) By Other Compositions: Antioxidants, Additives, Specialty Nutrients
Parenteral Nutrition Market Trends Shaping Long-Term Demand
Leading companies in the parenteral nutrition market are focusing on developing innovative formulations, such as high-calorie amino acid, glucose, electrolyte, fat, and multivitamin injections, to enhance nutritional support for individuals with chronic conditions. These specific injections are intravenous formulations that provide comprehensive macronutrient and micronutrient support for patients unable to meet their nutritional needs orally or enterally. For instance, in November 2024, Otsuka Pharmaceutical Factory, a Japan-based pharmaceutical company, launched KIDPAREN Injection, which is designed for high-calorie parenteral nutrition in patients with chronic kidney disease. This formulation aims to improve patient care by delivering extensive nutrient support, optimizing energy intake, and assisting overall metabolic requirements in the management of chronic kidney disease.
Parenteral Nutrition Market Leading Companies And Competitive Benchmarking
Major companies operating in the parenteral nutrition market are Fresenius Kabi, Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc., Otsuka Pharmaceutical Co Ltd, Claris Lifesciences Limited, Sichuan Kelun Pharmaceutical Co Ltd, JW Pharmaceuticals, Aculife Healthcare Pvt Ltd, Aspen Pharmacare, Ajinomoto Co Inc, Braun Medical Inc, Laboratoires Aguettant, AnazaoHealth Corporation, Baxter Healthcare Corporation, Sichuan Pharmaceutical Co, Calea UK, Meiji Holdings Co Ltd, United Pharmaceuticals, BioScrip Inc.
View The Full Parenteral Nutrition Market Report:
Parenteral Nutrition Market Top Region By Revenue And Market Share
North America was the largest region in the parenteral nutrition market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the parenteral nutrition market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model